Mitsushige Sugimoto - Concepedia

Author

Mitsushige Sugimoto

Hamamatsu University School of Medicine ORCID

Also Known As

M SUGIMOTO, M Sugimoto, M. SUGIMOTO, M. Sugimoto, M. Sugimoto, Mitsushige SUGIMOTO, Mitsushige Sugimoto, Sugimoto, M.

362

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Hamamatsu University School of Medicine Shiga University of Medical Science Shiga University of Medical Science Hospital Oita University Tokyo Medical University Hospital

About

Mitsushige Sugimoto is an author at Hamamatsu University School of Medicine specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	32	1.3K
2	Health Sciences	5	5	166
3	Public Health	5	5	360
4	Allergy	2	2	42
5	Engineering	1	1	80

Mitsushige Sugimoto

118

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease Kenichiro Takahashi, Atsushi Nishida, Takehide Fujimoto, Digestion	2016	583
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease Kyohei Nishino, Atsushi Nishida, Ryo Inoüe, Journal of Gastroenterology	2017	458
Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population Akira Andoh, Atsushi Nishida, Kenichiro Takahashi, Journal of Clinical Biochemistry and Nutrition	2016	248
Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to<scp>CYP</scp>2C19 genotype Takuma Kagami, Shu Sahara, H. Ichikawa, Alimentary Pharmacology & Therapeutics	2016	247
Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells Masashi Ohno, Atsushi Nishida, Yoshihiko Sugitani, PLoS ONE	2017	193
Pharmacogenomics-based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori Takahisa Furuta, Naohito Shirai, Makoto Kodaira, Clinical Pharmacology & Therapeutics	2007	183
Evidence that the Degree and Duration of Acid Suppression are Related to <i>Helicobacter pylori</i> Eradication by Triple Therapy Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Helicobacter	2007	147
Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score Waku Hatta, Yosuke Tsuji, Toshiyuki Yoshio, Gut	2020	147
Different effects of polymorphisms of tumor necrosis factor‐alpha and interleukin‐1 beta on development of peptic ulcer and gastric cancer Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Journal of Gastroenterology and Hepatology	2006	137
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease Atsushi Nishida, Kentaro Hidaka, Toshihiro Kanda, Inflammatory Bowel Diseases	2016	127

Page 1